Nutrient quality
Apigenin is clearly identified, but the standard capsule lacks absorption technology or source-purity details. The 50 mg apigenin amount reaches a high-potency supplemental range.
. Amazon | $ 19.99 | |
| $ 19.99 | ||
| $ 19.99 |
Apigenin offers a focused calming pathway that may help some people settle before bed. Human sleep evidence is limited, so the ingredient should be viewed as targeted support rather than a predictable sleep solution.
The full-strength amount is easy to assess in a single-active formula. Missing source and delivery details leave some uncertainty about ingredient quality and absorption.
Full-strength apigenin amount is the clearest strength. Human sleep evidence is limited is the main trade-off for someone comparing similar options.
Apigenin is clearly identified, but the standard capsule lacks absorption technology or source-purity details. The 50 mg apigenin amount reaches a high-potency supplemental range.
.Active ingredients have stated amounts and no proprietary blend hides a dose. Serving count is supplied, while full directions and the other-ingredients list are missing.
.The supplied aggregate rating is the only evidence of general satisfaction and its reliability depends on rating volume. No comment-level evidence is available to assess recurring complaints or confirm how experience matches the intended purpose.
.The active quality and serving utility support reasonable value. The product is reasonably competitive, though stronger values are available.
.Apigenin is a calming flavonoid with a plausible GABA-related mechanism, and the 50 mg serving reaches a high-potency target. The one-capsule amount is clearly disclosed.
Human sleep evidence remains limited, and the label provides no source purity or absorption technology. The serving may cause drowsiness, so it is not appropriate before driving or other alertness-dependent tasks.
No linked studies yet.
| Ingredient | Amount per serving |
|---|---|
Apigenin | 50 mg |
The disclosed apigenin amount matches the collection’s high-potency target. The standard capsule lacks stated absorption technology, and neither source purity nor a complete excipient profile is provided. Cost per target dose remains favorable.